Ending a three-day losing streak, Gilead Sciences (NASDAQ:GILD) traded higher on Friday after Jefferies touted the antiviral drugmaker as a potential obesity play, citing its oral GLP-1 candidate GS-...
Source LinkEnding a three-day losing streak, Gilead Sciences (NASDAQ:GILD) traded higher on Friday after Jefferies touted the antiviral drugmaker as a potential obesity play, citing its oral GLP-1 candidate GS-...
Source Link
Comments